Heterogeneity and diversity of IgM and IgG lupus anticoagulants in an individual with systemic lupus erythematosus.
From one patient with systemic lupus erythematosus retaining lupus anticoagulant (LAC), we established 6 Epstein-Barr virus-transformed human B cell clones secreting antibodies that affect the coagulation assay. Two and 4 of the clones secreted IgM and IgG antibodies, respectively. Although all 6 antibodies displayed anticardiolipin activity in ELISA, the increased binding activity in the presence of beta 2-glycoprotein I was limited only to the IgG antibodies. Five antibodies (two IgM and three IgG) had LAC activity which prolonged the activated partial thromboplastin time (APTT), whereas one IgG antibody shortened the APTT. Two of the IgG producing clones had an identical Ig heavy chain gene rearrangement despite their opposite effects on the coagulation assay. These results demonstrated the heterogeneity of LACs and diversity among their physiological functions.
Nakamura
N
N
Department of Nursing, School of Allied Health Sciences, Faculty of Medicine, Osaka University, Japan.
Azuma
C
C
Akamizu
T
T
Sugawa
H
H
Matsuda
F
F
Mitsuda
N
N
Honjo
T
T
Mori
T
T
Yamaji
K
K
D000328:Adult; D000911:Antibodies, Monoclonal; D001402:B-Lymphocytes; D015139:Blotting, Southern; D002461:Cell Line, Transformed; D002999:Clone Cells; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D014644:Genetic Variation; D004854:Herpesvirus 4, Human; D006801:Humans; D007074:Immunoglobulin G / Q000096:biosynthesis*; D007132:Immunoglobulin Isotypes / Q000096:biosynthesis; D007075:Immunoglobulin M / Q000096:biosynthesis*; D016682:Lupus Coagulation Inhibitor / Q000502:physiology*; D008180:Lupus Erythematosus, Systemic / Q000276:immunology*
D000911:Antibodies, Monoclonal; D007074:Immunoglobulin G; D007132:Immunoglobulin Isotypes; D007075:Immunoglobulin M; D016682:Lupus Coagulation Inhibitor